Team
NOVAiCOS ImmunoTherapeutics is led by a team of professionals driven by passion and dedication to innovation and scientific research. We work together to develop groundbreaking solutions in the field of immunotherapy for bone health.
Leadership Team
Dr. Giovanni CERUTTI
Pharmaceutical Chemist & Technologist, Former Pharma Business Head (Novartis & GE Healthcare groups)
President of the Board of Directors CEO & Managing Director NIT
Prof. Umberto DIANZANI
MD, PhD, Professor of Immunology UniUPO
Scientific Advisory Board Major Owner & Co-Founder President Scientific Advisory Board NIT
Dr. Ilaria ROATO
Researcher, Surgical Sciences UniTO
Member of the Board of Directors Chief Scientific Officer NIT
Dr. Dario VIGNANI
CFO - Novartis Group
Member of the Board of Directors Chief Financial & ERC Officer NIT
Scientific Advisors
Dr. Maurizio MARIANI
President and CEO Bridge4Pharma s.r.l. Scientific and Strategic Partnering in R&D Programs
Dr. Daniela CHICCO
CEO Bridge4Pharma S.r.l. Scientific and Strategic Partnering in R&D Programs
Dr. Mario MAIO
MM Pharma Consulting Technology Transfer, CMC Project Management
We are committed to maintaining the highest standards of scientific rigor, transparency, and reliability at every stage of research and development. Every decision is guided by our responsibility toward patients, the scientific community, and the environment.
We believe in the power of synergy and teamwork, valuing the diversity of skills and perspectives. We foster an inclusive environment based on mutual respect, professional growth, and knowledge sharing to achieve common goals.
Partners
We collaborate with strategic partners to accelerate innovation and
advance pioneering solutions in bone health.
